We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Home-Care Program for Bone Marrow Patients

By HospiMedica staff writers
Posted on 08 Nov 2006
A new study shows that patients in need of autologous stem-cell transplantation (ASCT) can undergo this treatment from their own homes, adding a positive impact to the patient's recovery. More...


Researchers from the Institut Clínic of Haematology and Oncology of Hospital Clínic at the University of Barcelona (Barcelona, Spain) followed 178 patients who underwent ASCT for a hematologic malignancy--including such diseases as myeloma, lymphoma, and leukemia--between November 2000 and February 2005. A total of 50 patients were treated with an at-home ASCT program in which prophylactic ceftriaxone and treatment of febrile neutropenia with piperacillin and tazobactam were introduced to minimize the readmission rate. The results were compared with those from 50 other patients with similar characteristics who, despite their appropriateness for the home-care program, were hospitalized conventionally.

The results showed that febrile neutropenia occurred in fewer patients in the at-home group as compared with the hospitalized group, and duration of fever was also shorter in the at-home group. Hospital readmission in the at-home group was required in only four cases (8%). This resulted in a reduction of 18.6 days of hospitalization per patient. Total median hospital charges were approximately half in the at-home group as compared with the in-hospital group. The results were published in the October 20, 2006, issue of the Journal of Clinical Oncology.

"This study has demonstrated that autologous bone marrow transplant can be done ambulatorily in a safe way and with important advantages for the patient. From our start in 2000, one out of three patients is treated at home, a mean of 12-15 patients per year,” said lead author Dr. Francesc Fernández-Avilés.

In order to receive home transplantation, patients needed to meet several requirements, the most important being voluntary participation in the program, having somebody to take care of them 24 hours a day, living relatively close to the hospital, and having the required hygienic conditions at home in order to avoid complications. Appropriate patients underwent preparatory treatment and bone-marrow infusion at the hospital and then returned home, where they were subsequently supervised by a group of nursing staff who monitored the patients daily for fever or other possible complications.



Related Links:
University of Barcelona

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
New
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.